NIH Awards The Texas Heart Institute $1.14 Million to Develop a Novel, First-in-Class Drug for Atherosclerotic Cardiovas...Texas Heart Institute
NIH Awards The Texas Heart Institute $1.14 Million to Develop a Novel, First-in-Class Drug for Atherosclerotic Cardiovas...Texas Heart Institute
Targeting Mitochondria 2023 will Highlight Stealth BioTherapeutics Latest Advancements in Mitochondrial Medicine...Mitochondria-Microbiota Task Force
Histiocytosis is a group of disorders characterized by abnormal increases in histiocytes like macrophages...The Institute of Medical Science, The University of Tokyo
